LBTSF (Almirall) Total Equity: $1,743 Mil (As of Mar. 2026)


LBTSF Almirall SA LBTSF
85 GF Score
Price $15.35
GF Value $16.92
! 4 Warning Signs
View Full Analysis

What is Almirall Total Equity?

Almirall LBTSF 85 Total Equity is $1,743 Mil as of Mar. 2026. GuruFocus rates LBTSF with a GF Score™ of 85/100 and a GF Value™ of $16.92. The stock has 4 warning signs investors should review.

Almirall's total equity for the quarter that ended in Mar. 2026 was $1,743 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Almirall Total Equity Historical Data

* Premium members only.

The historical data trend for Almirall's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Total Equity Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,453.15 1,396.94 1,595.86 1,558.52 1,741.38

Almirall Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,621.95 1,687.55 1,731.34 1,741.38 1,742.66
LBTSF
85GF Score
Almirall SA LBTSF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Almirall's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2736.691-995.316
=1,741

Almirall's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2693.642-950.983
=1,743

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $1,743 Mil mean?
Almirall (LBTSF) has a Total Equity of $1,743 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Almirall and its competitors.
Is Almirall's Total Equity too high?
Almirall's current Total Equity is $1,743 Mil. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Total Equity compare to ZTS and UTHR?
Almirall's Total Equity of $1,743 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Almirall and its competitors. Almirall's current Total Equity is $1,743 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Total Equity of $1,743 Mil. The stock's GF Value™ is $16.92, compared to a current price of $15.35 — trading 9.3% below its estimated fair value. The current Total Equity is $1,743 Mil. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Almirall (LBTSF), the current Total Equity is $1,743 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 9.3% below its estimated GF Value™ of $16.92.

Key valuation signals for LBTSF:

  • Total Equity: $1,743 Mil
  • GF Value™: $16.92 vs. price of $15.35 (9.3% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score

Get the complete analysis for LBTSF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$16.92
GF Value